The Leukemia & Lymphoma Society of Canada Revenue

Non-profit Organizations • Toronto, Ontario, Canada • 51-100 Employees

The Leukemia & Lymphoma Society of Canada revenue & valuation

Annual revenue	$6,159,960
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Non-profit Organizations industry and current estimated revenues	$19,800,000
Total funding	No funding

Key Contacts at The Leukemia & Lymphoma Society of Canada

Vanessa Nasrallah

National Director, Oty

Jeffrey Bacha

Board Of Directors

Sofia Guay

Executive Director, Revenue Development

Ryan O'Quinn

National Business Development & Advancement Director

Richard Piticco

Board Director; Member Of The Audit & Investment Committees

Ben Neumer

Director, Fundraising And Volunteer Engagement

Diana Bilyk

Campaign Director

Michael Berlando

Talent & Culture Director

Catalina Jimenez

Peer To Peer National Campaign Director

Patricia Gilmore

Director Business Transformation

Company overview

Headquarters	Toronto, Ontario, Canada
Phone number	+1107623654
Website	bloodcancers.ca
Keywords	Advocacy, Patient Services, Blood Cancer Research
Founded	1955
Employees	51-100
Socials

The Leukemia & Lymphoma Society of Canada Email Formats

The Leukemia & Lymphoma Society of Canada uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@lls.org), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@lls.org	100%

About The Leukemia & Lymphoma Society of Canada

The Leukemia & Lymphoma Society of Canada (LLSC) is a voluntary health agency dedicated to blood cancer. LLSC funds lifesaving blood cancer research across Canada and worldwide, and provides free information and support services. We won’t stop until there is a cure for leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative neoplasms and are able to improve the quality of life of people affected by blood cancers and their families by funding life-enhancing research and providing educational resources, services and support. Our strategy to achieve the mission is based on three areas of focus: research, patient support and advocacy. In 2017, we invested almost $7.4 million in the creation of programs and delivery of services to improve the lives of Canadians affected by blood cancers from coast to coast. This investment included a commitment of over $4.1 million in innovative, life-changing research to accelerate new cancer treatments, therapies, and cures; and $3.3 million towards funding patient services, programs and education across Canada. Everything we do is made possible through the generosity of individuals, corporate partners, and foundations. In the last two decades alone, the Leukemia & Lymphoma Society of Canada has raised $207 million for research and services. We receive no government support.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Manager

Director

Entry

Employees by Department

The Leukemia & Lymphoma Society of Canada has 21 employees across 8 departments.

Departments

Number of employees

Funding Data

The Leukemia & Lymphoma Society of Canada has never raised funding before.

The Leukemia & Lymphoma Society of Canada Tech Stack

Discover the technologies and tools that power The Leukemia & Lymphoma Society of Canada's digital infrastructure, from frameworks to analytics platforms.

jQuery CDN

CDN

PWA

Miscellaneous

Drupal

CMS

Cloudflare

CDN

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

PHP

Programming languages

AddToAny

Widgets

Bootstrap

UI frameworks

Splide

JavaScript libraries

Amazon Web Services

PaaS

Acquia Cloud Platform

PaaS

Frequently asked questions

The Leukemia & Lymphoma Society of Canada is located in Toronto, Ontario, CA.

You can reach The Leukemia & Lymphoma Society of Canada at +1107623654.

The Leukemia & Lymphoma Society of Canada generates an estimated annual revenue of $6,159,960. This revenue figure reflects the company's market position and business performance in its industry.

The Leukemia & Lymphoma Society of Canada has an estimated valuation of $19,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

The Leukemia & Lymphoma Society of Canada was founded in 1955, making it 71 years old. The company has established itself as a significant player in its industry over this time.

The Leukemia & Lymphoma Society of Canada has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.